A Study to Evaluate the Use of the Drug Combination Vorinostat, Niacinamide, and Etoposide in Patients With Lymphoid Malignancies That Have Reoccurred (SAHA)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by Columbia University
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Owen A. O'Connor, Columbia University
ClinicalTrials.gov Identifier:
NCT00691210
First received: June 3, 2008
Last updated: January 27, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2014
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)
No publications provided by Columbia University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):